Posts tagged “Salix”
Study suggests relief is in site for patients receiving medical treatment for prostate cancer. Drug may have a new purpose.
Salix produces 13-cent a share profit as sales far outpace expenses; Inspire cuts losses as co-marketed drug sales increase; Icagen reports a loss but notes progress on drugs.
Deloitte says leading technology firms increase revenues by 599 percent over five years. TriVirix revenues soar 8881 percent.'Rising Stars' include PowerByHand, LVL7.
Pharmaceutical firm says Colazal revenue climbs 46 percent, beats analyst expectations. New drug now hitting market. CFO sees $100 million in revenue this year.
<b>Updated:</b> Narrows net loss and grows revenue, on 53 percent increase in Colazal sales. Continued growth will lead to profitability in 2004, Salix says, as stock jumps 17 percent.